Breast Cancer Clinical Trial
— eCareOfficial title:
Cancer Caregivers and Their Struggle(s) Between Work and Family
Verified date | February 2024 |
Source | University of Colorado, Denver |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This randomized control trial will investigate the ability of an effective stress management psychoeducation program for employed caregivers to mitigate psychological distress and pathophysiology in spousal or partnered caregivers of patients' diagnosis with a solid tumor cancer of any stage. It is expected that improving caregiver status will have reduced depressive symptoms.
Status | Active, not recruiting |
Enrollment | 510 |
Est. completion date | September 30, 2024 |
Est. primary completion date | September 30, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 64 Years |
Eligibility | Inclusion Criteria: DISEASE CHARACTERISTICS (Meets all of the following criteria): Patients who have a primary diagnosis of solid tumor cancer at any stage that are within 12 weeks +/- of starting treatment, which includes either infusion chemo- or immunotherapy, oral targeted agents, or both. PATIENT CHARACTERISTICS: - Patients who have a primary diagnosis of soled tumor cancer at any stage that are within 12 weeks of initiating treatment. - Patient must be spouse or partner of the caregiver for at least a year and must live with caregiver - Must be able to read/speak English - 18 years of age or older CAREGIVER CHARACTERISTICS: - A primary caregiver for the patient with a diagnosis of solid tumor cancer at any stage who are within 12 weeks of initiating treatment - Spouse or partner of the patient for at least a year - The caregiver must live with the patient - Must be available to fully participate in an intervention (Virtual-PEPRR or PepPal) if assigned - Must score 1 or greater on the PHQ-2 (depression) and/or GAD-2 (anxiety) during pre-screening. - Must be employed at the time of the patient's diagnosis for a minimum of 20 hours/week with plans to remain employed and working during their patient's treatment. Caregivers that were furloughed or laid off due to Covid-19 who are actively looking for work will be included. - Able to read and speak the English language - Willingness to use a Smartphone - Age 25 (inclusive) 65 (non-inclusive) Exclusion Criteria: - Having a serious medical condition likely to influence neuroendocrine parameters - Chronic use of steroid medications - If Female, pregnant or planning to become pregnant in the next year - History of a psychiatric illness unrelated to their experience as a caregiver with the past 18 months. |
Country | Name | City | State |
---|---|---|---|
United States | University of Colorado Hospital | Aurora | Colorado |
Lead Sponsor | Collaborator |
---|---|
University of Colorado, Denver | National Cancer Institute (NCI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Caregiver: Change in Center for Epidemiological Studies Depression Scale (CESD) | Change in caregiver depressive symptoms. Center for Epidemiological Studies Depression Scale (CESD) is a self-report 20-item scale designed to measure current depressive symptoms. Total score range from 0-60, with a score at or above 16 reflecting significant depressive symptomatology. | Baseline, 3 months, 6 months, 9 months, 12 months follow up | |
Secondary | Caregiver: Change in Spielberger State-Trait Anxiety Inventory (STAI) | Change in caregiver anxiety. The "Spielberger State and Trait Anxiety Inventory" (STAI) is a validated self-reporting instrument used to assess anxiety in adults. The inventory consists of state anxiety, which evaluates how the subject feels currently (transient anxiety). The scale consists of 20 questions, and a higher score indicates greater anxiety. Total score ranges from 20 (no anxiety) to 80 (maximum anxiety). | Baseline, 3 month, 6 month, 9 month, 12 month follow up | |
Secondary | Caregiver: Change in Perceived Stress Scale (PSS) | Change in caregiver perceived stress. The "Perceived Stress Scale" (PSS) measures the overall level of stress. This instrument contains 14 items accessing overall appraisals of stress in the past month. The total score range is 0-56. A higher score indicates greater stress. | Baseline, 3 month, 6 month, 9 month, 12 month follow up | |
Secondary | Caregiver: Health Care Utilization | Caregiver electronic health records and supplemented by Colorado All Payer Claims Data and self-report | Baseline, 12 month follow up | |
Secondary | Caregiver: Change in Adrenal Activity Over Time | Cortisol measured in hair will be used as a retrospective measure of activation of the hypothalamic pituitary adrenal axis. | Baseline, 3 month, 6 month, 9 month, 12 month follow up | |
Secondary | Caregiver: Change in Caregiver Telomere Length Over Time | Telomere length was assessed as a measure of cellular aging in blood samples from participants. | Baseline, 3 month, 6 month, 9 month, 12 month follow up | |
Secondary | Patient: Change in Center for Epidemiological Studies Depression Scale (CESD) | Change in patient depressive symptoms. Center for Epidemiological Studies Depression Scale (CESD) is a self-report 20-item scale designed to measure current depressive symptoms. Total score range from 0-60, with a score at or above 16 reflecting significant depressive symptomatology. | Baseline, 3 month, 6 month, 9 month, 12 month follow up | |
Secondary | Patient: Change in Spielberger State-Trait Anxiety Inventory (STAI) | Change in patient anxiety. The "Spielberger State and Trait Anxiety Inventory" (STAI) is a validated self-reporting instrument used to assess anxiety in adults. The inventory consists of state anxiety, which evaluates how the subject feels currently (transient anxiety). The scale consists of 20 questions, and a higher score indicates greater anxiety. Total score ranges from 20 (no anxiety) to 80 (maximum anxiety). | Baseline, 3 month, 6 month, 9 month, 12 month follow up | |
Secondary | Patient: Change in Perceived Stress Scale | Change in patient perceived stress. The "Perceived Stress Scale" (PSS) measures the overall level of stress. This instrument contains 14 items accessing overall appraisals of stress in the past month. The total score range is 0-56. A higher score indicates greater stress. | Baseline, 3 month, 6 month, 9 month, 12 month follow up | |
Secondary | Patient: Health Care Utilization | Patient electronic health records and supplemented by Colorado All Payer Claims Data | Baseline, 12 month follow up | |
Secondary | Patient: Change in MD Anderson Symptom Inventory (MDASI) | Patient symptom management. the MD Anderson Symptom Inventory (MDASI) core scale, which assesses 13 symptoms (pain, fatigue, nausea, disturbed sleep, distress, shortness of breath, memory problems, lack of appetite, drowsiness, dry mouth, numbness, sadness, and vomiting) on a 0-10 scale. | Baseline, 3 month, 6 month, 9 month, 12 month follow up | |
Secondary | Caregiver: Employment status | Caregiver self-report employment and weekly hours worked questions from Current Population Survey (CPS) | Baseline, 12 month follow up | |
Secondary | Caregiver: Job Satisfaction | Caregiver self-report job satisfaction. Job satisfaction is measured by a single-item assessment tool assessing whether or not the participant was satisfied with their current job. Satisfaction was measured on a 0-7 scale. Higher score indicates a higher level of satisfaction. | Baseline, 12 month follow up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |